All News about Travere Therapeutics Inc
![](https://cdn.benzinga.com/files/images/story/2023/01/31/biotech_shutter.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Travere Therapeutics
January 30, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
4 Analysts Have This to Say About Travere Therapeutics
December 05, 2022
Via Benzinga
Where Travere Therapeutics Stands With Analysts
December 05, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9095.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/14/aapharma_10.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
Travere Therapeutics Provides Corporate Update and 2023 Outlook
January 09, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5627.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/14/aapharma_5.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23351.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21987.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_8593.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
Travere Therapeutics to Present at Upcoming Investor Conferences
November 09, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3394.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/01/biotech6.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
Travere Therapeutics Reports Third Quarter 2022 Financial Results
October 27, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9009.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5471.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
Travere Therapeutics to Report Third Quarter 2022 Financial Results
October 20, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://ml.globenewswire.com/media/e7252f5a-bd9e-4e33-9eb0-153976c06a3f/small/travere-txtm-inline-fullcolor-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19176.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.